Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Molecular Cancer Therapeutics|October 21, 2024
Soluble CD146 Cooperates with VEGFa to Generate an Immunosuppressive Microenvironment in CD146-Positive Tumors: Interest of a Combined Antibody-Based TherapyAhmad Joshkon, Wael Traboulsi, Magali Terme, et al.Biomedicines|December 23, 2020
Role of CD146 (MCAM) in Physiological and Pathological Angiogenesis-Contribution of New Antibodies for TherapyAhmad Joshkon, Xavier Heim, Cléa Dubrou, et al.European Heart Journal. Acute Cardiovascular Care|June 11, 2014
Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in sudden DEath) studyJean-Philippe Empana, Chantal M Boulanger, Muriel Tafflet, et al.Circulation|May 20, 2009
Microparticles from ischemic muscle promotes postnatal vasculogenesisAurelie S Leroyer, Téni G Ebrahimian, Clément Cochain, et al.Circulation. Cardiovascular Genetics|December 25, 2009
Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaquesManuel Mayr, David Grainger, Ursula Mayr, et al.Nature Cardiovascular Research|August 22, 2025
Region-specific gene expression and sex inform about disease susceptibility in the aortaMilagros C Romay, Feiyang Ma, Ana Mompeón, et al.Journal of the American College of Cardiology|May 28, 2013
Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosisGabrielle Sarlon-Bartoli, Youssef Bennis, Romaric Lacroix, et al.Circulation Research|June 21, 2008
Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb musclesAndrea Caporali, Elisabetta Pani, Anton J G Horrevoets, et al.Haematologica|June 27, 2012
Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysisRomaric Lacroix, Laurent Plawinski, Stéphane Robert, et al.Acta Neuropathologica Communications|October 24, 2022
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastomaAhmad Joshkon, Emeline Tabouret, Wael Traboulsi, et al.Pageof 2